Shimadzu Collaborates with University Medical Center Göttingen

Published on: 
Column, December 2022, Volume 18, Issue 12
Pages: 9

Shimadzu (Duisburg, Germany) has announced a collaboration with the
University Medical Center Göttingen (UMG) (Germany). The collaboration will focus on the development of new clinical laboratory methods using liquid chromatography–mass spectrometry (LC–MS) for therapeutic drug monitoring (TDM) analysis.

TDM plays an important role in providing precision medical care; TDM analysis measures the concentration of drugs currently in the blood to determine the next dosage of a drug. Working together with Prof. Andreas Fischer, Dr. Frank Streit, and other leading experts at UMG, new methods for multiple target groups of drugs will be developed and optimized so that clinical laboratories can switch methods quickly and easily. Speeding up this process will give doctors, clinics, and hospitals treating emergency cases quicker access to better test results, and ultimately lead to better medical care for emergency patients.

The collaboration with UMG takes place with the help and support of Shimadzu’s European Innovation Center (EUIC) programme.


For more information please visit